SMO ClinPlus Co. Ltd.
SMO ClinPlus CO.,LTD. provides site management services in research development in pharmaceuticals, medical devices, and health-related products in China. The company offers early modeling, preliminary preparation plan trial site initiation, on-site execution, and project management services. SMO ClinPlus CO.,LTD. was founded in 2009 and is based in Shanghai, China.
Market Cap & Net Worth: SMO ClinPlus Co. Ltd. (301257)
SMO ClinPlus Co. Ltd. (SHE:301257) has a market capitalization of $648.86 Million (CN¥4.76 Billion) as of March 18, 2026. Listed on the SHE stock exchange, this China-based company holds position #11667 globally and #2800 in its home market, demonstrating a -5.87% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SMO ClinPlus Co. Ltd.'s stock price CN¥60.26 by its total outstanding shares 79004770 (79.00 Million).
SMO ClinPlus Co. Ltd. Market Cap History: 2022 to 2026
SMO ClinPlus Co. Ltd.'s market capitalization history from 2022 to 2026. Data shows growth from $392.24 Million to $648.86 Million (1.58% CAGR).
SMO ClinPlus Co. Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SMO ClinPlus Co. Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.36x
SMO ClinPlus Co. Ltd.'s market cap is 0.36 times its annual revenue
0.68x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
2.73x
SMO ClinPlus Co. Ltd.'s market cap is 2.73 times its annual earnings
359.02x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $392.24 Million | $586.23 Million | $72.41 Million | 0.67x | 5.42x |
| 2023 | $521.25 Million | $760.04 Million | $134.73 Million | 0.69x | 3.87x |
| 2024 | $290.30 Million | $803.73 Million | $106.43 Million | 0.36x | 2.73x |
Competitor Companies of 301257 by Market Capitalization
Companies near SMO ClinPlus Co. Ltd. in the global market cap rankings as of March 18, 2026.
Key companies related to SMO ClinPlus Co. Ltd. by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #91 globally with a market cap of $176.18 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #154 globally with a market cap of $120.38 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.34 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #512 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #91 | Thermo Fisher Scientific Inc | NYSE:TMO | $176.18 Billion | $470.00 |
| #154 | Danaher Corporation | NYSE:DHR | $120.38 Billion | $191.39 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.34 Billion | $586.37 |
| #512 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
SMO ClinPlus Co. Ltd. Historical Marketcap From 2022 to 2026
Between 2022 and today, SMO ClinPlus Co. Ltd.'s market cap moved from $392.24 Million to $ 648.86 Million, with a yearly change of 1.58%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥648.86 Million | +15.80% |
| 2025 | CN¥560.35 Million | +93.03% |
| 2024 | CN¥290.30 Million | -44.31% |
| 2023 | CN¥521.25 Million | +32.89% |
| 2022 | CN¥392.24 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of SMO ClinPlus Co. Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $648.86 Million USD |
| MoneyControl | $648.86 Million USD |
| MarketWatch | $648.86 Million USD |
| marketcap.company | $648.86 Million USD |
| Reuters | $648.86 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.